// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Validity of Patient-reported Cardiovascular Events in a Large Longitudinal Cohort of Patients with Psoriatic Arthritis and Psoriasis

Vinod Chandran - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Transient Ischemic Attack

N/A

What Influences Patients’ Opinion of Remission and Low Disease Activity in Psoriatic Arthritis? Principal Component Analysis of an International Study

Danielle Robinson - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

What Is the Impact of Discrepancy Between Central and Local Readers in Evaluation of MRI Scans on the Classification of Axial Spondyloarthritis? Data from the ASAS Classification Cohort Study

Susanne Juhl Pedersen - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

What Is the Impact of MRI on the Performance of the ASAS Classification Criteria in Patients Presenting with Undiagnosed Back Pain?

Raj Carmona - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Psoriasis

N/A

When Will I Get past This Exhaustion? Predictors of Improved Fatigue in the First Year of RA

Orit Schieir - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Withdrawal of Ixekizumab Results in Loss of Efficacy in Multiple Clinical Domains in Patients with Psoriatic Arthritis Who Had Achieved Minimal Disease Activity: Results from the SPIRIT-P3 Study

Sreekumar Pillai - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

LY2439821

SUN-093 Early Life Exposure to High Fat Diet Induces Extensive Changes in the Adult Brain

Anna Roy - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Autism

N/A

SUN-114 Microglia Interact with Hypothalamic Progenitors during Development and Are Required for Proper Energy Balance

Jessica Rosin - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Bisphenol A

SUN-LB018 Role of BMAL1 in Western Diet-Induced Disruption of Circadian Hypothalamic Feeding Neuropeptides

Matthew Clemenzi - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

Neuropeptide Y

SAT-347 Unfolding Generates an Active CYP11A1 for Mitochondrial Integration and Activity

Himangshu Bose - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

SAT-360 Acute Stress Increases Local Corticosterone Levels In Lymphoid Organs Of Neonatal Mice: Analysis Using LC-MS/MS

Jordan Hamden - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Glucocorticoid

MON-370 Isolated Secondary Adrenal Insufficiency in the Absence of Hypophysitis Secondary to Immune Checkpoint Inhibitors

Mary Lu - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Hydrocortisone

SUN-529 Burden of Illness in Adults with Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry

Priya Kishnani - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypophosphatasia

Alkaline phosphatase

SUN-537 Progesterone Therapy and Serum Sclerostin Levels in Healthy Menopausal Women: A 3-month Randomized, Placebo Controlled Clinical Trial

Yuebo Yang - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Progesterone Oral

MON-534 Reduced PTH Levels in Adolescents with Anorexia Nervosa: Implication for Kidney and Bone

Nina Lenherr-Taube - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Anorexia nervosa

Ergocalciferol

OR13-4 Safety Profile of Asfotase Alfa Treatment of Patients with Hypophosphatasia: A Pooled Analysis

Michael Whyte - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Cardiac arrest

Strensiq

OR03-5 Fractures during Bisphosphonate Therapy after Orthotopic Liver Transplantation: Incidence and Predictors

Marie-Josée Bégin - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

γδ T Cells Mediate αβ T Cell Activation in Angiotensin II-Induced Hypertension

Antoine Caillon - American Society of Hypertension (ASHy) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Angiotensin II

Association Between Non-Oral Hormonal Contraceptives and Blood Pressure

Cindy Z Kalenga - American Society of Hypertension (ASHy) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Role of Vγ6+ γδ T Cells in Angiotensin Il-Induced Hypertension and Vascular Injury

Ahmad Mahmoud - American Society of Hypertension (ASHy) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Angiotensin II

Copyright © 2026. QuantiNova All rights reserved